Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| ca gleason in level prostate |
|
Olsson,CA Olsson CA (C A), 0, 0, 0, 221, 0, 149 model fitted for preoperative prostate-specific antigen (PSA) level, Gleason sum and pathological stage were used University of California - UC Newsroom | Accurate, Straightforward Accurate, Straightforward Method to Predict Prostate Cancer Risk characteristics such as the PSA level and Gleason grade (a pathologist's measure of how PCHRD Library General Health arrow Cholesterol level tied to prostate Ca prognosis "The risk of having high-grade disease Gleason score of 7 or higher was reduced The Journal of Urology : Genetic Profiling of Gleason Grade 4/5 Gleason grade 4/5 tissue, the primary cause of failure to cure prostate cancer, Relative quantitation of transcript level and fold difference were Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Recurrent prostate cancer patient, Age (y), Race, Serum prostateāspecific antigen* (ng/mL), Gleason sum, Bone metastases, Androgen deprivation therapy Prostate specific antigen level and Gleason score in predicting patientās Gleason score and level of PSA. Lymph node metastasis was confirmed by CT guided .. Perez CA. Carcinoma of the prostate: a model for A Racial Comparison of Gleason Score, Prostate Specific Antigen Conclusion: AA men were more likely to be diagnosed with a higher Gleason scores prostate cancer than CA men. The disparity may be because of the later Dr. Rose's Peripheral Brain--PROSTATE CANCER In a series of 49 men with clinically localized prostate Ca (T1 or T2; Gleason scores 5-6) followed for mean 32mos, the rate of change of serial (us. Case Report Isolated Prostate Cancer Recurrence Presenting as biopsy for a PSA level of 6 ng/mL. One year later, with. a PSA level of 9 ng/mL, he underwent a containing Gleason score 8 to 10 prostate cancer but in Correlation of Proton MR Spectroscopic Imaging with Gleason Score CONCLUSION: MR spectroscopic imaging measurement of prostate tumor (Cho + Cr)/Cit MR spectroscopic imaging parameters at various Gleason score levels, Sialyl-lewis-X, Gleason grade and stage in non-metastatic human estimation of the levels of prostate specific antigen (PSA) in *Tel: 403-492-4585; E-mail: hidikio@gpu.srv.ualberta.ca. IngentaConnect Postoperative radiotherapy in 423 patients with A high (>25 ng/mL) preoperative PSA level was also a predictor of tumor The treatment outcome was poor in pT3bN0 and Gleason score 7-10 patients, Oncology: Gleason score in prostate ca: what does it mean? Oncology: Gleason score in prostate ca: what does it mean? prostate-specific antigen (PSA) level (an indicator of total body tumour burden), Prostate stem cell antigen (PSCA) expression increases with high 1Department of Urology, University of California, Los Angeles, California, The level of PSCA expression increased with higher Gleason score (P=0.016), Race/Literacy Effects on Prostate Ca Biology & Access We evaluate the relation of race and literacy with Gleason score, PSA level and treatment. Methods: Newly diagnosed prostate cancer patients were recruited Prostate : BC Cancer Agency High risk: stage T2c or PSA level >20 ng/mL or Gleason score >=8 up-to-date information: http://www.bccancer.bc.ca/PPI/TypesofCancer/Prostate/default.htm. Method for prognosis of prostate cancer - Patent 5858681 The method of claim 1, wherein the level of the thymosin Ī²15 protein is measured. .. Ca Gleason 6 .about. 8 25 4 7 14 Ca Gleason 9 .about. 10 Combination of prostate-specific antigen, clinical stage, and RESULTS: Prostate-specific antigen level, TNM clinical stage, and Gleason score contributed significantly to the prediction of pathological stage (P<.001). |
| ca gleason in level prostate |
|
biopsy effects prostate side abstinence congestion due prostate blog massage prostate spot 2006 awareness cancer month prostate |